2,3-piperidinedicarboxylic acid has been researched along with Reperfusion Injury in 1 studies
2,3-piperidinedicarboxylic acid: effective antagonist at all three types of excitatory amino acid receptors; does not depress responses to acetylcholine or substance P
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weber, M | 1 |
| Bonaventure, N | 1 |
| Sahel, JA | 1 |
1 other study available for 2,3-piperidinedicarboxylic acid and Reperfusion Injury
| Article | Year |
|---|---|
Protective role of excitatory amino acid antagonists in experimental retinal ischemia.
Topics: Animals; Disease Models, Animal; Dizocilpine Maleate; Electroretinography; Excitatory Amino Acid Ant | 1995 |